A few updates from the AlphaRose team:

Science: We accomplished a major milestone, as our safety study for Rosiphersen come back with no adverse events, which gives us great confidence for success in our first in-human study. Our next steps will be looking at biodistribution from that study, GMP manufacturing, and setting up our IND enabling studies.

Fundraising: We have extended our Seed Round till August 28th. We're excited about this opportunity for investors to come in at the ground floor on this round, the momentum we're building, and the incredible team of investors that are coming together to support our vision.

The People Magazine full page story has now just hit the shelves today. Pick up a copy the next time you get a haircut! :)

Onward!

Casey McPherson
Ceo/Founder
512.940.4164

PS: We are doing an "Intro to AlphaRose Live" for interested investors June 25th 11:00CST - click here if you'd like to join! https://app.livestorm.co/p/eeacbc44-8a04-492c-bd74-1f107c032627